Mark Brantly, MD
University of Florida, Gainesville, FL, USA
2
2
2
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Charlie Strange, MD
Medical University of South Carolina
Shared therapeutic areas:
Jeanine D'Armiento, MD, PhD
Alpha-1 Foundation
Shared therapeutic areas:
Ed Doo, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Monica Goldklang, MD
Columbia University
Shared therapeutic areas:
Charlton Strange, MD
Medical University of South Carolina, Charleston, SC, USA
Shared therapeutic areas:
Worked with same sponsors:
Stephen Wisniewski, PhD
University of Pittsburgh
Shared therapeutic areas:
Mark Brantly, MD
University of Florida
Shared therapeutic areas:
John Magee, MD
University of Michigan Medical Center, Ann Arbor
Shared therapeutic areas:
David A. Brenner, MD
The University of California, San Diego
Shared therapeutic areas:
Terence R. Flotte, MD
UMass Medical School
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Safety Dose Finding Study of ADVM-043 Gene Therapy to Treat Alpha-1 Antitrypsin (A1AT) Deficiency
All 2 trials loaded